Novo Nordisk A/S ADR buy BMO Capital Markets
Start price
18:30
/
50%
€115.00
Target price
08.08.25
€146.66
Performance (%)
2.17%
Price
21:57
€117.50
Summary
This prediction is currently active. With a performance of 2.17%, the BUY prediction by BMO_Capital_Markets for Novo Nordisk A/S ADR is trending in the right direction. This prediction currently runs until 08.08.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Novo Nordisk A/S ADR | 2.17% |
iShares Core DAX® | -5.630% |
iShares Nasdaq 100 | -8.559% |
iShares Nikkei 225® | -9.576% |
iShares S&P 500 | -6.631% |
Comments by BMO_Capital_Markets for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target lowered by analysts at BMO Capital Markets from $170.00 to $160.00. They now have an "outperform" rating on the stock.
Ratings data for NVO provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€137.00
25.06.24
25.06.24
€152.14
25.06.25
25.06.25
-14.23%
21:57
21:57
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€119.50
12.04.24
12.04.24
€153.17
12.04.25
12.04.25
-1.67%
21:57
21:57